Cited by 664Adipokines, Inflammation, and Metabolic DiseasesLipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.

C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study

Rutter, Martin K., Meigs, James B., Sullivan, Lisa M., D’Agostino, Ralph B., Wilson, Peter W.F.·2004·Circulation

DOI 10.1161/01.cir.0000136581.59584.0e

Open this paper in CoChat — free account

Abstract

Background— Inflammation (assessed by C-reactive protein [CRP]) and the metabolic syndrome (MetS) are associated with cardiovascular disease (CVD), but population-based data are limited. Methods and Results— We assessed the cross-sectional relations of CRP to the MetS (National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Adult Treatment Panel III definition) in 3037 subjects (1681 women; mean age, 54 years) and the utility of CRP and the MetS to predict new CVD events (n=189) over 7 years. MetS (≥3 of 5 traits) was present in 24% of subjects; mean age-adjusted CRP levels for those with 0, 1, 2, 3, 4, or 5 MetS traits were 2.2, 3.5, 4.2, 6.0, or 6.6 mg/L, respectively ( P trend <0.0001). In persons with MetS, age-adjusted CRP levels were higher in women than men (7.8 versus 4.6 mg/L; P <0.0001). MetS and baseline CRP were individually related to CVD events (for MetS: age-sex-adjusted hazard ratio [HR], 2.1; 95% CI, 1.5 to 2.8; for highest versus lowest CRP quartile: HR, 2.2; 95% CI, 1.4 to 3.5). Greater risk of CVD persisted for MetS and CRP even after adjustment in a model including age, sex, MetS (HR, 1.8; 95% CI, 1.4 to 2.5), and CRP (HR, 1.9; 95% CI, 1.2 to 2.9). The c-statistic associated with the age- and sex-adjusted model including CRP was 0.72; including MetS, 0.74; and including CRP and MetS, 0.74. Conclusions— Elevated CRP levels are related to insulin resistance and the presence of the MetS, especially in women. Although discrimination of subjects at risk of CVD events using both MetS and CRP is not better than using either phenotype alone, both CRP and MetS are independent predictors of new CVD events.

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000136581.59584.0e

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction: A Potential Role for Cytokines Originating From Adipose Tissue?
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,366
Self-citation
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women
Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292
Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study
Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O’Reilly, D. S. J., Haffner, S. M., Isles, C., Macfarlane, P. W., Packard, C. J., Cobbe, S. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000080897.52664.94 · Cited by 1,506
Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study
Schmidt, M. I., Duncan, B. B., Sharrett, A. R., Lindberg, G., Savage, P. J., Offenbacher, S., Azambuja, M. I. R., Tracy, R. P., & HEISS, G. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01046-6 · Cited by 1,080
Elevated Levels of Acute-Phase Proteins and Plasminogen Activator Inhibitor-1 Predict the Development of Type 2 Diabetes
Festa, A., D’Agostino, R., Tracy, R. P., & Haffner, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1131 · Cited by 1,057
Self-citation
Is Type II diabetes mellitus a disease of the innate immune system?
Pickup, J. C., & Crook, M. A. (1998) · Diabetologia · doi:10.1007/s001250051058 · Cited by 1,042

Show all 36 references

Research works printed but not linked: 7

10.1161/atvb.19.4.972 · DOI
10.1161/circ.102.1.42 · DOI
10.1161/str.32.11.2575 · DOI
1998, Diabetologia, 4, 1241
2003, Clin Chem Lab Med, 41, 1120
10.1210/jcem.86.9.7873 · DOI · Paper page
10.1001/jama.1991.03460050081025 · DOI

Sorted by citations

Items 401–500 of 662

Identifying metabolic syndrome in a clinical cohort: Implications for prevention of chronic disease
Martin, A. M., Neale, E. P., Batterham, M. J., & Tapsell, L. C. (2016) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2016.09.007 · Cited by 15
Prediction of 10-year mortality using hs-CRP in Chinese people with hyperglycemia: Findings from the Da Qing diabetes prevention outcomes study
Qian, X., He, S., Wang, J., Gong, Q., An, Y., Li, H., Chen, Y., & Li, G. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108668 · Cited by 15
Correlation between reduction of superior interventricular groove epicardial fat thickness and improvement of insulin resistance after weight loss in obese men
Liang, K., Tsai, I., Lee, W., Lin, S., Lee, W.-L., Lee, I., Fu, C., Wang, J., & Sheu, W. H. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-115 · Cited by 15
The Potential Role of Aerobic Exercise-Induced Pentraxin 3 on Obesity-Related Inflammation and Metabolic Dysregulation
Slusher, A. L., Huang, C., & Acevedo, E. O. (2017) · Mediators of Inflammation · doi:10.1155/2017/1092738 · Cited by 15
“These findings have contributed to the utilization of CRP, but not SAP, as an indirect clinical marker of inflammatory disease status, particularly in cardiovascular disease and metabolic dysregulation [30].”
Background
Increased lipoprotein(a) in metabolic syndrome: is it a contributing factor to premature atherosclerosis?
Bozbaş, H., Yı́ldı́rı́r, A., Pirat, B., Eroğlu, S., Korkmaz, M. E., Atar, İ., Ulus, T., Aydınalp, A., Özin, B., & Müderrisoğlu, H. (2008) · PubMed · Cited by 15
Cardiovascular Risk and the Metabolic Syndrome
Rutter, M. K., Meigs, J. B., & Wilson, P. W. F. (2006) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2006.4.252 · Cited by 15
Self-citation
Coronary Risk Factors: An Overview
Lloyd‐Jones, D. M., & Kannel, W. B. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_128 · Cited by 15
Evidence for no global effect of metabolic syndrome per se on early hypertensive sequelae
Tsioufis, C. P., Tsiachris, D., Dimitriadis, K. S., Chartzoulakis, G., Selima, M., Chatzis, D., Taxiarchou, E., Stefanadis, C., & Kallikazaros, I. E. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f430b0 · Cited by 15
Highly sensitive C-reactive protein and male gender are independently related to the severity of coronary disease in patients with metabolic syndrome and an acute coronary event
Monteiro, C. M. C., Pinheiro, L. F., Izar, M. C. D. O., Barros, S. W., Vasco, M. B., Fischer, S. M., Póvoa, R., Brandão, S. A. B., dos Santos, A. O., Oliveira, L. J. G. D., et al. (2010) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2010005000008 · Cited by 15
“Among novel risk markers, elevated highly sensitive C-reactive protein (hsCRP) levels were related to the MetS, and both hsCRP and MetS were independent predictors of new cardiovascular events (5).”
Background
Dyslipidemia in South Asians living in a western community
Kolluri, R., Pinedo, D., Edmondson-Holt, A., Grewal, K., & Falko, J. M. (2008) · Journal of clinical lipidology · doi:10.1016/j.jacl.2008.12.002 · Cited by 14
Cross‐sectional and Longitudinal Relationships between Perceived Stress and C‐reactive Protein in Men and Women
Barbosa‐Leiker, C., Roper, V., McPherson, S., Lei, M., Wright, B. R., Hoekstra, T., & Kostick, M. (2013) · Stress and Health · doi:10.1002/smi.2507 · Cited by 14
Inflammation markers as mediators of vasculo-endothelial dysfunction and atherosclerosis in the metabolic syndrome.
Rizvi, A. A. (2007) · PubMed · Cited by 15
Metabolic factors and high-sensitivity C-reactive protein: the HUNT study
Laugsand, L. E., Åsvold, B. O., VATTEN, L. J., Romundstad, P., Wiseth, R., Hveem, K., & Janszky, I. (2011) · European Journal of Preventive Cardiology · doi:10.1177/1741826711417758 · Cited by 14
Urinary Malondialdehyde Is Associated with Visceral Abdominal Obesity in Middle‐Aged Men
Lee, S. M., Cho, Y. H., Lee, S. Y., Jeong, D. W., Cho, A.-R., Jeon, J. S., Park, E., Kim, Y. J., Lee, J. G., Yi, Y. H., et al. (2015) · Mediators of Inflammation · doi:10.1155/2015/524291 · Cited by 14
“Alanine aminotransferase (ALT) [7], γ-glutamyl transferase (GGT) [8], uric acid [9], and Creactive protein (CRP) [10] are suggested to be metabolic markers associated with hepatic dysfunction, oxidative stress, and inflammation.”
Change in Serum Bilirubin Level as a Predictor of Incident Metabolic Syndrome
Lee, Y., Lee, S.-E., Jun, J. E., Jee, J. H., Bae, J. C., Jin, S., & Kim, J. H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168253 · Cited by 14
Metabolic Syndrome and Preeclampsia
Hubel, C. A., & Roberts, J. M. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374213-1.00007-0 · Cited by 15
Impact of prolonged maraviroc treatment on non-AIDS-related comorbidities in HIV-positive patients: a retrospective cohort study
Piconi, S., Foschi, A., Malagoli, A., Carli, F., Zona, S., Milić, J., Ricci, E. D., Rizzardini, G., & Guaraldi, G. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz227 · Cited by 14
Hipertensión arterial y síndrome metabólico
Cordero, A., Moreno, J., & Alegría, E. (2005) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(05)74119-4 · Cited by 14
Serum C-reactive protein levels correlates better to metabolic syndrome defined by International Diabetes Federation than by NCEP ATP III in men
Lin, M., Shih, S., Li, H., Chuang, L., Chang, T., Wei, J., Shieh, G.-J., Chien, Y.-F., Hua, C., & Hwang, J. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.11.013 · Cited by 14
Metabolic syndrome management
Stone, N. J., & Schmeltz, L. R. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.13.2059 · Cited by 14
Circulating adipokines and insulin resistance in subjects with combined cardiac and metabolic syndrome X
Liang, K., Lee, W., Lee, W.-L., Liao, Y., Wang, K., Lee, I., Wang, J., & Sheu, W. H. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0078-4 · Cited by 13
“We and others have demonstrated that patients of MetX had decreased circulating adiponectin but increased leptin and a higher inflammatory status [6–8].”
Background
Gut microbiota from Mexican patients with metabolic syndrome and HIV infection: An inflammatory profile
Amador-Lara, F., Andrade-Villanueva, J. F., Vega‐Magaña, N., Rodríguez, M. P., Álvarez-Zavala, M., Sánchez-Reyes, K., Toscano-Piña, M., Peregrina-Lucano, A. A., del Toro‐Arreola, S., González-Hernández, L. A., et al. (2022) · Journal of Applied Microbiology · doi:10.1111/jam.15505 · Cited by 13
“…biomarker hsCRP were statistically higher in the HIV + MetS group vs HIV group; hsCRP is a known predictor of cardiovascular risk (Ridker et al., 2000; Rutter et al., 2004); therefore, we propose conducting these set of tools and marker (cardiometabolic indexes and hsCRP, respectively) routinely…”
Method
Association between residence near surface coal mining and blood inflammation
HENDRYX, M. S., & Entwhistle, J. (2015) · The Extractive Industries and Society · doi:10.1016/j.exis.2015.01.006 · Cited by 13
Fatty liver and chronic inflammation in Chinese adults
Wang, P., Hsieh, C., Psang, L.-C., Cheng, Y., Liou, C., Weng, S., Chen, J., Chen, I., Li, R.-H., & Eng, H. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.04.014 · Cited by 13
Inflammation and Oxidative Stress are Associated with the Prevalence of High Aankle-brachial Index in Metabolic Syndrome Patients without Chronic Renal Failure
Zhang, Y., Chen, J., Zhang, K., Kong, M., Wang, T., Chen, R., Wang, L. H.-C., Wang, J., & Huang, H. (2013) · International Journal of Medical Sciences · doi:10.7150/ijms.5308 · Cited by 13
Importance of Diagnosing and Treating the Metabolic Syndrome in Reducing Cardiovascular Risk
Smith, S. R. (2006) · Obesity · doi:10.1038/oby.2006.292 · Cited by 13
“(8) found that CRP levels, an inflammatory marker linked to CVD, were increased in patients who had three or more components of the metabolic syndrome.”
Background
Prevalencia de síndrome metabólico
Cordero, A., Alegría, E., & León, M. (2005) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(05)74115-7 · Cited by 13
The metabolic syndrome: A vascular perspective
Tamsma, J. T., Jazet, I. M., Beishuizen, E. D., Fogteloo, A. J., Meinders, A. E., & Huisman, M. V. (2005) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2005.01.011 · Cited by 13
High sensitive c-reactive protein and serum amyloid a are inversely related to serum bilirubin: effect-modification by metabolic syndrome
Dullaart, R. P. F., Deetman, P. E., & Bakker, S. J. L. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.05.387 · Cited by 12
Association between restrictive pulmonary disease and type 2 diabetes in Koreans: A cross-sectional study
Lee, D., & Nam, S. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i10.425 · Cited by 12
The Association Between Inflammatory and Oxidative Stress Biomarkers and Plasma Metabolites in a Longitudinal Study of Healthy Male Welders
Gao, S., Quick, C., Guasch‐Ferré, M., Zhuo, Z., Hutchinson, J. M., Su, L., Hu, F. B., Lin, X., & Christiani, D. C. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s316262 · Cited by 13
Síndrome metabólico y complicaciones cardiovasculares en el paciente hipertenso
Costa, J. A., Rodilla, E., Cardona, J., González, C., & Pascual, J. M. (2011) · Medicina Clínica · doi:10.1016/j.medcli.2011.05.018 · Cited by 12
Metabolic Syndrome and Angiographic Coronary Artery Disease Prevalence in Association with the Framingham Risk Score
Konstantinou, D. M., Chatzizisis, Y. S., Louridas, G. E., & Giannoglou, G. D. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0059 · Cited by 12
Exploring the usefulness of inflammation-sensitive biomarkers to reveal potential sex differences in relation to low-grade inflammation in individuals with the metabolic syndrome
Rogowski, O., Shapira, I., & Berliner, S. A. (2008) · Metabolism · doi:10.1016/j.metabol.2008.04.015 · Cited by 12
“Moreover, existing evidence also suggests that CRP might be more strongly correlated with MetS in women than in men [28,32-34].”
Background
Left ventricular hypertrophy and microalbuminuria in patients with essential hypertension.
Monfared, A., Salari, A., Mirbolook, F., Momeni, M., Shafighnia, S., Shakiba, M., & Sheikholeslami, A. (2013) · Iranian Journal of Kidney Diseases · Cited by 12
Contribution of classical and emerging risk factors to coronary artery disease in Asian Indians
Shanker, J., & Kakkar, V. V. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.03.012 · Cited by 13
Association between Lung Function and Metabolic Syndrome Independent of Insulin in Japanese Men and Women
Yamamoto, Y., Oya, J., Nakagami, T., & Uchigata, Y. (2014) · Japanese Clinical Medicine · doi:10.4137/jcm.s13564 · Cited by 12
The association between elevated body mass index and wide blood chemistry panel results in apparently healthy individuals
Ziv‐Baran, T., Wasserman, A., Goldiner, I., Stark, M., Shenhar‐Tsarfaty, S., Rozenbaum, Z., Galmor, L., Shapira, I., Zeltser, D., Berliner, S. A., et al. (2022) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2022.07.019 · Cited by 11
Cost-effectiveness of rosuvastatin for primary prevention of cardiovascular events according to Framingham Risk Score in patients with elevated C-reactive protein.
MacDonald, G. P. (2010) · PubMed · Cited by 11
High-Sensitivity C-Reactive Protein Is Independently Associated With Arterial Stiffness in Women With Metabolic Syndrome
Oh, E. G., Kim, S. H., Bang, S. Y., Hyun, S. S., Im, J.-A., Lee, J. E., & Yoo, J. Y. (2012) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e31820e5a91 · Cited by 11
Serum visfatin levels do not increase in post-menopausal women with metabolic syndrome
Güdücü, N., İşçi, H., Görmüş, U., Yiğiter, A. B., & Dünder, İ. (2013) · Journal of Endocrinological Investigation · doi:10.1007/bf03346752 · Cited by 11
Metabolic syndrome and C-reactive protein concentration as independent correlates of chronic kidney disease
Yang, T., Chou, Y., Chu, C., Lin, S.-H., Hsieh, P., Hsu, C.-H., Bai, C.-H., You, S., & Sun, C.-A. (2014) · Endocrine Research · doi:10.3109/07435800.2013.840652 · Cited by 9
“However, other reports insisted that combining MetS and CRP data added little to cardiovascular disease and stroke risk prediction (8,29).”
Inflammation markers as mediators of vasculo-endothelial dysfunction and atherosclerosis in the metabolic syndrome and type 2 diabetes
Rizvi, A. A. (2007) · Chinese Medical Journal · doi:10.1097/00029330-200711010-00014 · Cited by 11
Adiponectin and Cardiovascular Disease
Jogi, M., & Bajaj, M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-141-3_10 · Cited by 11
Clinical significance of fatty liver associated with metabolic syndrome
Kogiso, T., Moriyoshi, Y., & Nagahara, H. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00116.x · Cited by 11
Inflammatory and Long-term Risk Markers
Levinson, S. S. (2006) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2006.06.001 · Cited by 11
Cardiorespiratory Fitness Does Not Offset Adiposity-Related Systemic Inflammation in Physically Active Older Women
Bergens, O., Nilsson, A. E., & Kadi, F. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00067 · Cited by 10
The metabolic health of young men conceived using intracytoplasmic sperm injection
Catford, S. R., Halliday, J. L., Lewis, S., O’Bryan, M. K., Handelsman, D. J., Hart, R. J., McBain, J., Rombauts, L. J. F., Amor, D. J., Saffery, R., et al. (2022) · Human Reproduction · doi:10.1093/humrep/deac212 · Cited by 12
The Relationship between the Severity of Coronary Artery Disease and Epicardial Adipose Tissue Depends on The Left Ventricular Function
Doesch, C., Süselbeck, T., Haghi, D., Streitner, F., Schoenberg, S. O., Borggrefe, M. M., & Papavassiliu, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048330 · Cited by 10
High-sensitivity C-reactive protein predicts target organ damage in Chinese patients with metabolic syndrome
Zhao, Z., Nie, H., He, H., Yan, Z., Liu, D., Luo, Z., Ma, L., Ni, Y., Chen, J., Jin, J., et al. (2007) · Metabolism · doi:10.1016/j.metabol.2007.06.030 · Cited by 10
“030 strong and independent risk predictor for future cardiovascular morbidity and mortality in this population [1,2].”
BackgroundResultInfluential
Definitions and mechanisms of the metabolic syndrome
Meigs, J. B. (2006) · Current Opinion in Internal Medicine · doi:10.1097/01.med.0000216957.13633.58 · Cited by 10
Self-citation
Usefulness of Microalbuminuria in Patients With the Metabolic Syndrome to Predict Subclinical Atherosclerosis and Cardiovascular Disease Outcomes
Afonso, L., Hari, P., Kondur, A., Veeranna, V., Manickam, P., Simegn, M. A., Jacob, S., & Ference, B. A. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.05.028 · Cited by 10
Using structural equation model to illustrate the relationship between metabolic risk factors and cardiovascular complications in Taiwan
Lin, J., Hwang, J., Dai, D., & Tseng, Y.-Z. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000230095.65062.a9 · Cited by 10
Variation in CHI3LI in Relation to Type 2 Diabetes and Related Quantitative Traits
Rathcke, C. N., Holmkvist, J., Jørgensen, T., Borch‐Johnsen, K., Hansen, T. F., Pedersen, O. B., & Vestergaard, H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005469 · Cited by 10
Novel cardiovascular risk factors in the elderly and their correlation with the Framingham risk score
Halil, M. G., Yavuz, B., Doğu, B. B., Cankurtaran, M., Dede, D. Ş., Ülger, Z., Barak, A., Karabulut, E., Aytemir, K., Kabakçı, G., et al. (2008) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3282f394a5 · Cited by 10
Relating statin therapy to C-reactive protein levels
Doggrell, S. A. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.9.1597 · Cited by 10
“However, there is some evidence for gender difference in the relationship between CRP levels, the metabolic syndrome and cardiovascular risk, where a relationship has clearly been shown in women [11] but is not so clearcut in men [12-15].”
Background
High-sensitivity C-reactive protein use in cardiovascular risk screening at 6 to 12 months postpartum following hypertensive disorders of pregnancy
Johnstone, A. M., Pudwell, J., Ackerman‐Banks, C. M., Lundsberg, L. S., Lipkind, H. S., & Smith, G. N. (2022) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2022.100776 · Cited by 9
Effect of Curcumin on Serum Cathepsin D in Patients with Metabolic Syndrome
Shirmohammadi, L., Ghayour‐Mobarhan, M., Saberi‐Karimian, M., Iranshahi, M., Tavallaie, S., Emamian, M., & Sahebkar, A. (2019) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x19666190919110652 · Cited by 9
Metabolic Syndrome and Related Inflammation, Prevalence, and Predictive Value of C-Reactive Protein in South Asian Youths
Malik, M. S., Malik, M., Sukhera, A. B., Khalid, M. A., Waqas, A., Qayyum, W., Butt, A. F., Baig, A. A., Butt, A. A., & Malik, F. S. (2021) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2021.0016 · Cited by 9
Plasma visfatin/nicotinamide phosphoribosyltransferase (visfatin/NAMPT) concentration in elderly subjects with metabolic syndrome
Kocełak, P., Olszanecka‐Glinianowicz, M., Owczarek, A. J., Krupa, W., Obirek, P., Bożentowicz‐Wikarek, M., Brzozowska, A., Mossakowska, M., Zdrojewski, T. R., Skalska, A., et al. (2015) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.2878 · Cited by 9
Study of insulin resistance in patients with systemic lupus erythematosus and rheumatoid arthritis
Elzorkany, K. M. A., Essa, E. S., Fayez, D., Gazareen, S., Dawood, A. A., & Elnajjar, M. M. (2014) · Menoufia Medical Journal · doi:10.4103/1110-2098.141634 · Cited by 9
Combined effect of C-reactive protein gene SNP +2147 A/G and interleukin-6 receptor gene SNP rs2229238 C/T on anthropometric characteristics among school children in Taiwan
Lin, F.-H., Chu, N.-F., Lee, C., Hung, Y.-J., & Wu, D.-M. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.195 · Cited by 9
Nuevas estrategias en prevención cardiovascular
Cordero, A., Alegría‐Barrero, E., Moreno, J., Fernández, E., & Saénz, J. D. (2017) · Revista de medicina de la Universidad de Navarra · doi:10.15581/021.7545 · Cited by 9
Relationships between intrauterine fetal growth trajectories and markers of adiposity and inflammation in young adults
Yadav, A., Beilin, L. J., Huang, R., Vlaskovsky, P., Newnham, J. P., White, S. W., & Mori, T. A. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01203-2 · Cited by 8
“High-sensitivity Creactive protein (hs-CRP), an acute phase reactant secreted from the liver, has been shown to be consistently associated with atherosclerosis [9, 10].”
Background
Do statins reduce events in patients with metabolic syndrome?
Towne, S. P., & Thara, E. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-008-0007-1 · Cited by 8
Asociación de la rigidez peneana nocturna con testosterona, síndrome metabólico y otras variables: un estudio piloto prospectivo transversal
Rajmil, O., Fernández-Miró, M., Blasco-Moreno, A., Arrús, J. A., Montañés, R., & Rodrı́guez-Espinosa, J. (2011) · Actas Urológicas Españolas · doi:10.1016/j.acuro.2011.03.014 · Cited by 8
Hypercholesterolemia, not metabolic syndrome, related to adhesion of monocytes to cultured endothelium in nondiabetic subjects
Lee, I., Lin, T. M., Lee, W., Ou, H., Chien, Y.-H., Lee, W.-L., Tang, Y., Yang, C.-H., & Sheu, W. H. (2005) · Metabolism · doi:10.1016/j.metabol.2005.05.012 · Cited by 8
“Emerging evidence indicates that metabolic syndrome is not only associated with inflammation but also important in atherosclerosis and coronary heart disease [12-14].”
Background
Health and fertility of ICSI-conceived young men: study protocol
Catford, S. R., Lewis, S., Halliday, J. L., Kennedy, J., O’Bryan, M. K., McBain, J., Amor, D. J., Rombauts, L. J. F., Saffery, R., Hart, R. J., et al. (2020) · Human Reproduction Open · doi:10.1093/hropen/hoaa042 · Cited by 8
Aqueous extract of Solanum macrocapon Linn leaf abate diabetic cardiomyopathy by attenuating oxidative stress and inflammation in rats
Osukoya, O. A., Ajiboye, B. O., Oyinloye, B. E., Owero-ozeze, O. S., Ojo, O. A., & Kappo, A. P. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14172 · Cited by 8
Biomarkers of inflammation, endothelial dysfunction and insulin resistance in adults of Inner Mongolia, China
Wang, G., Liu, Y., Wang, A., Tong, W., & Zhang, Y. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1108 · Cited by 8
“The epidemiological data have indicated that subjects with insulin resistance or metabolic syndrome are in a proinflammatory state [11,20,21].”
Background
Renal Dysfunction and Inflammatory Markers in Hypertensive Patients seen in a University Hospital
Braga, F. L. M., de Arruda, I. K. G., Diniz, A. D. S., Cabral, P. C., de Lemos, M. D. C. C., Braga, M. D. M., & Chaves, H. (2013) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20130102 · Cited by 8
Screening and risk stratification of patients with the metabolic syndrome and diabetes
Wong, N. D. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.4.2.181 · Cited by 8
Comparison of Atherosclerotic Calcification Burden in Persons With the Cardiometabolic Syndrome and Diabetes
Wong, N. D., Gransar, H., Shaw, L. J., Polk, D. M., & Berman, D. S. (2006) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2006.05618.x · Cited by 8
Metabolic Syndrome and C-reactive Protein among Cardiology Patients
Chapidze, G., Dolidze, N., Enquobahrie, D. A., Kapanadze, S., Latsabidze, N., & Williams, M. A. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.03.011 · Cited by 8
C-Reactive Protein in Cardiovascular Disease
Tousoulis, D., Androulakis, E. S., & Παπαγεωργίου, Ν. (2013) · CRC Press eBooks · doi:10.1201/b15301-3 · Cited by 8
Interleukin-15 in Hypertension: Further Insights into Inflammation and Vascular Disease
Lim, H. S., & Lip, G. Y. H. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.03.742 · Cited by 8
“12 The high sensitivity C-reactive protein has been shown to increase with the number of components of the metabolic syndrome and we have also reported similar findings with plasma von Willebrand factor (a plasma marker of endothelial damage/dysfunction) in patients with hypertension”
Result
Lifestyle Modification in Prediabetes and Diabetes: A Large Population Analysis
Dansinger, M. L., Gleason, J. A., Maddalena, J., Asztalos, B. F., & Diffenderfer, M. R. (2025) · Nutrients · doi:10.3390/nu17081333 · Cited by 13
“All assays were performed on Roche COBAS analyzers and had within-and between-run CVs of 4.0%, as previously described [15–21].”
Influential
Diabetes Mellitus Risk Prediction in the Framingham Offspring Study and Large Population Analysis
Ai, M., Otokozawa, S., Liu, C., Asztalos, B. F., Maddalena, J., Diffenderfer, M. R., Russo, G. T., Thongtang, N., & Dansinger, M. L. (2025) · Nutrients · doi:10.3390/nu17071117 · Cited by 9
“Fasting glucose and high-sensitivity C-reactive protein (hs-CRP) were measured using assays as previously described [6,18].”
Relationships Among C-Reactive Protein, Alanine Aminotransferase, and Metabolic Syndrome in Apparently Healthy Chinese Subjects
Huang, H.-H., Chen, Y., Chen, J.-S., Lin, J., Hsieh, C., Pei, D., & Wu, C. (2018) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2017.0059 · Cited by 7
“33 Through this study, we can understand further the clinical signiﬁcance of CRP and ALT. Subjects with higher ALT could be interpreted as having higher risk for MetS.”
Impact of excluding hyperglycemia from international diabetes federation metabolic syndrome diagnostic criteria on prevalence of the syndrome and its association with microvascular complications, in adult patients with type 1 diabetes
Lecumberri, E., Nattero‐Chávez, L., Quiñones‐Silva, J., Díaz, S. A., Fernández‐Durán, E., Avendaño, B. D., Escobar-Morreale, H. F., & Luque‐Ramírez, M. (2022) · Endocrine · doi:10.1007/s12020-022-03041-8 · Cited by 8
“This fact may be of utmost importance, since hs-CRP increases with the number of MetS components [26], and may predispose itself to an increased risk of cardiovascular events [27].”
Background
Determination of Sample Size and Errors
Abebe, H. T. (2022) · Chapman & Hall/CRC eBooks · doi:10.1201/9781003261148-27 · Cited by 7
Is there any putative mediatory role of inflammatory markers on the association between ultra-processed foods and resting metabolic rate?
Bahrampour, N., Shiraseb, F., Noori, S., Clark, C. C. T., & Mirzaei, K. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.932225 · Cited by 8
Metabolic Syndrome and C-Reactive Protein in American Adults: The Impact of Abdominal Obesity
Okosun, I. S. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0040 · Cited by 7
Increased Inflammation, Reduced Plasma Phospholipid Eicosapentaenoic Acid and Reduced Antioxidant Potential of Treated Hypertensive Patients with Metabolic Syndrome
Shin, M., Shim, E., Kang, B., Park, S., Lee, S., Shim, C. Y., Park, E., & Chung, N. (2009) · Yonsei Medical Journal · doi:10.3349/ymj.2009.50.6.757 · Cited by 7
Metabolically Healthy Obesity and Its Associates in Mongolian Chinese Adults
Zhang, M., Tong, W., Chen, J., Zhang, Y., & Li, S. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0102 · Cited by 7
“34,35 Family history of hypertension is an important risk factor for hypertension-related CVD. 36,37 It is likely that family history of hypertension reﬂects the contribution of genetic factors, although shared environmental factors are also involved in family history of hypertension.”
The New Unified International Diabetes Federation/American Heart Association/National Heart, Lung, and Blood Institute Metabolic Syndrome Definition: Does it Correlate Better with C-Reactive Protein in Chinese Patients Diagnosed with Type 2 Diabetes?
Lü, B., Zhang, S., Wen, J., Yang, Y., Yang, Z. H., Zhang, Z., Wang, X., & Hu, R. (2010) · Journal of International Medical Research · doi:10.1177/147323001003800605 · Cited by 7
C-reactive protein and chronic hepatitis C virus infection in diabetic patients
Skowroński, M., Zozulińska‐Ziółkiewicz, D., Juszczyk, J., Michalski, W., & Wierusz‐Wysocka, B. (2010) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.1001 · Cited by 7
Role of hs-CRP measurements in the current cardiovascular risk assessment
García–Moll, X., & Ordóñez‐Llanos, J. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.01.011 · Cited by 7
Percutaneous coronary intervention increases leptin and decreases adiponectin levels
Azar, R. R., Sarkis, A., Salameh, E., Gannagé‐Yared, M., Amm‐Azar, M., Badaoui, G., Germanos, M., & Kassab, R. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02654.x · Cited by 7
Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset
Martínez‐Urbistondo, D., Huerta, A. E., Navarro‐González, D., Sánchez‐Íñigo, L., Fernández‐Montero, A., Landecho, M. F., Martínez, J. A., & Delgado, J. P. (2023) · European Journal of Clinical Investigation · doi:10.1111/eci.14036 · Cited by 6
From circulating biomarkers to genomics and imaging in the prediction of cardiovascular events in the general population
Fava, C., Montagnana, M., Guidi, G. C., & Melander, O. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.582511 · Cited by 6
Distribution of C-reactive protein and its association with subclinical atherosclerosis in asymptomatic postmenopausal Chinese women
Yu, R., Ho, S. C., Lam, C. W. K., Woo, J., & Ho, S. S. Y. (2010) · Metabolism · doi:10.1016/j.metabol.2010.03.020 · Cited by 6
Interactions between CKD and MetS and the Development of CVD
Aihara, K., Mogi, M., Shibata, R., Bishop‐Bailey, D., & Ma, X. L. (2011) · Cardiology Research and Practice · doi:10.4061/2011/878065 · Cited by 5
Association of high sensitivity C-reactive protein concentrations and metabolic syndrome among Thai adults
Hillman, A. J., Lohsoonthorn, V., Hanvivatvong, O., & Jiamjarasrangsi, W. (2010) · Asian Biomedicine · doi:10.2478/abm-2010-0047 · Cited by 6
Low-Grade Inflammation and Ambulatory Blood Pressure Response to Antihypertensive Treatment: The ALPHABET Study
Fukutomi, M., Hoshide, S., Eguchi, K., Watanabe, T., & Kario, K. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt024 · Cited by 6
Significance of arterial stiffness and relationship with other noninvasive methods for the assessment of subclinical atherosclerosis inpatients with metabolic syndrome.
Mitu, F., Mitu, O., Dimitriu, C., Dimitriu, G., & Mitu, M. (2013) · The Medical-Surgical Journal · Cited by 6
Characterizing Decision-Analysis Performances of Risk Prediction Models Using ADAPT Curves
Lee, W., & Wu, Y. (2016) · Medicine · doi:10.1097/md.0000000000002477 · Cited by 6
Effects of acute cold exposure on plasma inflammatory and lipid biomarkers related to cardiovascular disease risk
Ullevig, S. L., Umeda, M., Chung, E., Sesatty, A. L., Samsuhadi, K. E., & Fogt, D. L. (2018) · Journal of Integrative Cardiology · doi:10.15761/jic.1000266 · Cited by 6
Metabolic Syndrome and Preeclampsia
Jeyabalan, A., Hubel, C. A., & Roberts, J. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407866-6.00007-9 · Cited by 6
Weak associations between prognostic biomarkers and disease in preliminary studies illustrates the breach between statistical significance and diagnostic discrimination
Levinson, S. S. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.01.015 · Cited by 6

Authors: Rutter, M. K., Meigs, J. B., Sullivan, L. M., D’Agostino, R. B., & Wilson, P. W. F.
Affiliations: Boston University (US)
ORCID: Rutter, Martin K.
Meigs, James B.
Sullivan, Lisa M.
D’Agostino, Ralph B.
Wilson, Peter W.F.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2004-07-27
Volume: 110
Issue: 4
Pages: 380-385
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.0000136581.59584.0e
OpenAlex: W1983997573
Cited by: 664
References: 36
Citations by year: 2026: 4 · 2025: 7 · 2024: 9 · 2023: 15 · 2022: 19 · 2021: 9 · 2020: 8 · 2019: 11 · 2018: 15 · 2017: 13 · 2016: 19 · 2015: 20 · 2014: 36 · 2013: 36 · 2012: 26
FWCI: 48.38
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Research Explorer (The University of Manchester) (submittedVersion)
Funders: National Institutes of Health (n01hc25195-41-0-1)
National Heart, Lung, and Blood Institute (R01HL073272, N01‐HC25195, R01-HL 073272-01)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: C-reactive protein, metabolic syndrome, cardiovascular risk prediction, inflammation, insulin resistance, sex differences, Framingham Offspring Study, cardiovascular events, risk discrimination, cardiovascular risk in women, NCEP ATP III criteria, Framingham risk score, Framingham risk equation
MeSH terms: Adult, Aged, Aged, 80 and over, C-Reactive Protein, Cardiovascular Diseases, Cross-Sectional Studies, Female, Follow-Up Studies, Humans, Inflammation, Insulin Resistance, Male, Middle Aged, Predictive Value of Tests, Risk, Sex Factors, Cohort Studies, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks